This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
BP plc (NYSE:BP) is getting done with the Deepwater Horizon fallout, and management has done a good job in improving the company's operations. New projects and cost-cutting allow for higher cash flows, and investors receive an attractive and safe dividend whilst waiting for the growth investments to pay off.
BP BLT BHP XOM BHPBF CVX BBL BHP TOT BHPLF
6-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
On Monday, June 25 while the stock market was under pressure as trade issues between the U.S. and trading partners around the world dominated the market's psyche, shares of Clean Energy Fuels (NASDAQ:CLNE) quietly rose to a new high. The final week of June also marks the end of the second quarter and the first half of 2018. With the heart of the summer season and the July 4 holiday right around the corner, the final week of June is often a time of window dressing in the stock market as traders and market participants look forward to vacations at the beach and other locations and time with family and friends.
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
NPSNY SYY RUTH LX MS DECK SRRK EQIX JACK MDT TACOW KNSA VZ ZOES FB CLPS QNST MCRI KR SMTC CCL RYDAF EVOP INTC DRRX ICLK MUSA ITUB BB UNFI RHT PTIE HLF JPM MU FNKO HBNC SBUX LOCO PLAY XOM TWX MS.PRE MS.PRF MS.PRG RDSB TOT RDSA MS.PRA SHAK HMNY SAFM BKS AAN OSTK GSKY INCY CTLR CCL BP MS.PRI GOOGL MS.PRK FLL RYDBF MKSI FITB CLR BB PPC BC NDLS DOGZ FND DRI SGBXQ FINL WGO COP XHR DAL ORCL DIS JASO F RDS.B RDS.A TACO DISH TMSR SPTN FDX VLO GOLF CHUY SNY CHEF W ITRM SGBX CVX SNE
6-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
The largest five individual stock positions are Cisco Systems, Berkshire Hathaway, Baidu Inc., Johnson & Johnson, and Alphabet, and they account for ~49% of the portfolio.
NOW PSX AZO RDSB TOT RDSA MRC RHHBF HSB RHHVF NWLI AMZN CSCO EMR CMCSK MMM WPP CTWS TMK HCS BRK.A AVT HEIO JNJ BK GOOGL RYDBF VZ NVS WFCNP AXELF HAL PM TMK WSM MTSI CCV DVN WFC.PRL AXP CCZ WFC.PRJ GOOG BAX SHEN VZA COP USB WFC.PRT CKX KOF WFC.PRR TMK.PRC WFC.PRQ ANAT TMK.PRB WFC.PRP WFC.PRO WFC.PRN JEF WFC.PRY RYDAF HSBC.PRA WFC.PRX BIDU HSBC WFC.PRW DEO WFC.PRV AGCO HBCYF WFC CTWSP FP WFC.WS HCS.PRB CTWSO SAFRY RDS.B UL RDS.A UNP UN CMCSA MA GSK 0005 SAF CCV.CL RHHBY KHC HSEA HSEB DNOW UNF
Despite their enticing nature, oil stocks are always tricky. Subject to multiple factors, particularly geopolitical pressures, the energy sector is often a hit-or-miss affair. Additionally, with the current Trump administration at the helm over unprecedented issues, this year should be especially unpredictable.
APC APA XOM HES LONE PXD DVN CXO RDSB TOT RDSA COP HES.PRA RYDAF FP RDS.B NBL RDS.A SNP CTLR PBR EOG BP CVX RYDBF MRO CLR WRD AEUA
32m - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
22h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TOT / Total S.A. on message board site Silicon Investor.
as of ET